NHS dietitian, Msc @FoodPolicyCity supporter of realistic, sustainable food choices for people living with long term health conditions.

London/ Birmingham
Joined July 2013
Ginny Eastwood, RD retweeted
🚨SURPASS-CVOT: What’s #tirzepatide’s REAL CV benefit vs placebo❓🚨 New Diabetes Care analysis uses imputed placebo comparison from REWIND Tirzepatide vs imputed placebo: 🔹 MACE-3: HR 0.72 (0.55 to 0.94) 🔸 All-cause mortality: HR 0.61 (0.45 to 0.82) ⚠️ Caveats matter: 1️⃣Cross-trial comparison, not direct RCT 2️⃣SGLT2i use 31% vs 0% in REWIND 3️⃣Only 21% of REWIND met SURPASS-CVOT criteria The real question: will regulators grant a CV indication? FDA may agree (they already gave dulaglutide one). But EMA/MHRA never added formal CV indication to dulaglutide despite REWIND. Stakes are high: licence change = guideline change = access change 🔗 doi.org/10.2337/dc26-0298
2
11
43
3,988
Ginny Eastwood, RD retweeted
An EASO publication in @NatureMedicine proposes a framework for diagnosing, staging & managing adult obesity. Prof. @busetto_luca highlights the need for comprehensive clinical evaluations beyond BMI. easo.org/professor-luca-buse…
2
8
24
5,266
The 'Decision Support Tool' for those living with #T1Diabetes Published January 2024 @NHSEngland Built with many living with #T1D and clinical colleagues in the #T1D space Do use, RT and cascade as you need to! (Also available in Bengali; Polish; Urdu & Punjabi) @BT1DUK @DiabetesUK @kamleshkhunti @GoggleDocs @NHSDiabetesProg @sugarydoc Link: england.nhs.uk/publication/d…
19
56
3,918
Ginny Eastwood, RD retweeted
While I’m happy that our 2011 mathematical model was used by @nesta_uk to estimate the step reduction in daily calories would be required to address obesity in the UK, I wish they had read our later studies. Unfortunately, a constant intensity intervention to reduce calorie intake typically results in exponential waning of the effect over time (not a sustained step reduction) and will therefore only result in about 20% of the weight loss they predicted.
Pleased to see @wesstreeting announce a new healthy food standard. Nesta first set out this policy in 2024 and we are delighted to welcome it today. Read more about the plan in The Observer with @RSylvester1 observer.co.uk/news/politics…
3
14
1
113
45,432
Ginny Eastwood, RD retweeted
The efficacy of intermittent scanning continuous glucose monitoring in the elderly*: A case-control study. *Older people Older people with diabetes benefit from is-CGM. HbA1c drops sustained for 2 years, few stop using it. More support for CGM in older age! #DiabetesCare
1
6
1
16
2,438
Ginny Eastwood, RD retweeted
Major survey of all Nutritionists and Dietitians in UK! #AcademyNutritionSciences want to hear from every #Nutritionist or #Dietitian What are your research experiences? Please take part, no matter whether you do no research, a little or a lot! qualtrics.kcl.ac.uk/jfe/form…
1
35
3
46
7,839
Ginny Eastwood, RD retweeted
Retrospective claims data reveals over 20 % of GLP-1 medicine users had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment. pdf.sciencedirectassets.com/…
7
39
4
158
27,189
Real-world comparison of semaglutide/tirzepatide (GLP‑1/GLP‑1+GIP) vs bariatric surgery. 📉 In a real-world matched study of 14,152 pts: At 2 years: • Surgery: −25.7% total weight loss (TWL) • GLP-1s (semaglutide/tirzepatide): −5.3% TWL (ITT); −7.6% (per-protocol) • HbA1c drop: Surgery −0.5 pts vs GLP-1s −0.2 pts (p<0.001) ⚖️ Conclusion: Surgery delivers greater, sustained weight loss & better glycemic control vs GLP-1s for eligible patients. soard.org/article/S1550-7289…
11
44
1
119
18,297
💉 GLP-1 meds don’t just curb appetite—sometimes they curb essential nutrients too. - - - 📉 In a study of 460,000+ adults on GLP-1s (mostly with T2D): 🔹13% developed nutritional deficiencies in 6 months 🔹22% within 12 months 🔹Vitamin D deficiency was most common (13.6%) 🔹3% experienced muscle loss 🔍 Patients who saw a dietitian were more likely to have deficiencies identified—not because dietitians caused harm, but because they actually looked. 💡 Clinical translation: 🔹Appetite suppression can lower intake of protein, vitamins (D, B12, folate), and minerals. 🔹Without supervision, this can compromise muscle mass, hydration, and metabolic health. 🔹Older adults and those with obesity are especially vulnerable due to baseline deficiencies. Treating obesity isn't just about weight loss—it's about preserving health while losing weight. ✅ That’s why supervised care with physicians + registered dietitians is non-negotiable. ✅ Monitor labs (Vit D, B12, iron, folate). ✅ Emphasize protein, strength training, and hydration. 📚sciencedirect.com/science/ar… Credit to @drbutsch and colleagues.
6
49
4
140
12,740
Realigning #diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies thelancet.com/journals/landi… #T1D #T2D #olderadults #FREE to read with registration (also FREE) #ADA2025
12
33
2,791
This is a very good review of type 2 diabetes jamanetwork.com/journals/jam…
2
100
1
429
34,299
Ginny Eastwood, RD retweeted
Addressing #obesity can help prevent T2D. @EASOobesity acknowledges the importance of addressing obesity as both a risk factor for diabetes — along with CVD and cancer — and a chronic disease in its own right. #EASOpolicy
5
8
420
Ginny Eastwood, RD retweeted
Standard of Care in 2025 #ADASciSessions #ADA2025
1
24
1
55
5,479
Ginny Eastwood, RD retweeted
Thrilled to finally share what has kept me occupied these past few months; our @TheLancet Series on early-onset type 2 diabetes is out! Has been an honour to be the Lead Author for this Series brining together global experts; thanks @callam_editor for inviting me People developing #T2D at young ages, lose ~15-20 years of lifespan ☹️ We highlight emerging evidence, major research gaps and emphasise the need for population-level prevention and precision care, both necessary to reverse this concerning trend. The articles are free to access until mid-August, please share widely (@ImperialMDR @ImperialMed @ImperialAHSC @ImperialBRC)! Paper 1: authors.elsevier.com/a/1lJZF… Paper 2: authors.elsevier.com/c/1lJZF… Paper 3: authors.elsevier.com/a/1lJZG… thanks to my fantastic co-authors (tagging the ones on here): @LeeLingLim1 @kamleshkhunti @CCikomola @Andrea_OY_Luk @Poojasachdev_dr @armocida_b
25
73
10
307
55,179
Today? #Mounjaro is launched into the #NHS Link: bbc.co.uk/news/articles/cglz… My views on it via @bmj_latest It now opens up a 2 tier system... "The interim guidance will also leave primary care clinicians in the lurch. Because only a fraction of the population will be eligible for tirzepatide, it will fall on clinicians to explain this “rationing.” Or, in some cases, the layered pathway to access the drug...." bmj.com/content/389/bmj.r923
16
21
3
76
13,388
Are you a member of the dietetic support workforce - or do you supervise, manage or work alongside them? Our brand new Roles and Responsibilities Guidance has been developed to support you in your role. ⭐ Access it here ⬇ bda.uk.com/practice-and-educ…
6
8
543
Ginny Eastwood, RD retweeted
💉 GLP-1 Dropouts: It’s not about willpower A 🇬🇧study (n=1,659) finds why patients stop: 🔹 43% = cost 🔸 14% = unmet expectations 🔹 12% = side effects 🔁 69% switched provider—not quit 📖 Also interesting insights into why start, and the lived experience 🎯 Real-world use is shaped by price, hype & support gaps. 🔗ggdocs.co/h6wf3h
16
30
2,327